Dry Eye Disease Clinical Trials

302 clinical trials for Dry Eye Disease across international registries, including 36 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease — RECRUITING · NA
• The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free — RECRUITING · PHASE4
• TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED) — RECRUITING · PHASE4
• A Clinical Study Evaluating Licaminlimab for Dry Eye Disease — RECRUITING · PHASE2
• Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease — RECRUITING · PHASE2
• Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease — RECRUITING · PHASE4
• An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease — RECRUITING · PHASE2
• A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK — RECRUITING · PHASE4
• Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops — RECRUITING · NA
• Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease — RECRUITING · NA
• Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease — RECRUITING · PHASE1
• Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity — RECRUITING
• BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber — RECRUITING · NA
• The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes — RECRUITING · NA
• The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function — RECRUITING · PHASE4
• Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED — RECRUITING · NA
• A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease. — RECRUITING
• Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye — RECRUITING · PHASE4
• 2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD — RECRUITING
• Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease — RECRUITING · NA
• Vit-A-Vision® Clinical Investigation — RECRUITING · NA
• Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients With Graves Disease — RECRUITING · NA
• Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon — RECRUITING
• New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye — RECRUITING · PHASE4
• Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery — RECRUITING · NA
• Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease — RECRUITING · NA
• Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom — RECRUITING · NA
• Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID) — RECRUITING
• Ocular Microbiome and Immune System in Dry Eyes — RECRUITING
• Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease — RECRUITING · PHASE3
• Role of Corneal Nerves in Dry Eye Disease — RECRUITING
• Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye — RECRUITING · PHASE4
• Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye — RECRUITING · NA
• Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease — RECRUITING · PHASE2
• The Pattern of Dry Eye Disease After Cataract Surgery — RECRUITING
• A MULTI-CENTER, DOUBLE-MASKED, RANDOMIZED, ONE-YEAR SAFETY STUDY OF EBI-005 5 MG/ML TOPICAL OPTHALMIC SOLUTION VERSUS VEHICLE-CONTROL IN SUBJECTS WITH DRY EYE DISEASE (DED) — RECRUITING
• Effect of topical hydrocortisone 0.335% (Softacort®) on ocular surface inflammation in patients with dry eye — COMPLETED · PHASE4
• A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study — COMPLETED
• POST CATARACT SURGERY DRY EYE DISEASE — NOT_YET_RECRUITING · NA
• An Evaluation of the Safety and Tolerability of Ocular Lubricants — COMPLETED · NA
• Effect of Oral Isotretinoin on Ocular Surface and Meibomian Glands — COMPLETED · NA
• SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease — COMPLETED · PHASE4
• Evaluate the Efficacy and Safety of Amnion Membrane Disc Allograft vs Standard of Care in Participants With Dry Eye Disease — NOT_YET_RECRUITING · PHASE4
• A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment — COMPLETED · PHASE4
• A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease — COMPLETED · PHASE2
• Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease — NOT_YET_RECRUITING · PHASE2
• A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease — ACTIVE_NOT_RECRUITING · PHASE3
• Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease — COMPLETED · PHASE4
• Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED). — COMPLETED · PHASE2
• Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye — NOT_YET_RECRUITING · PHASE3

Refine this search